脊髓十字征:遗传性痉挛性截瘫5型的潜在影像标志物
在25例SPG5患者和21名健康对照中,于T2*加权成像上评估颈髓十字征的形态与信号特征,并测量特定区域FA值。结果显示所有SPG5患者颈髓均出现十字征,背柱、腹索和中间带T2高信号发生率分别为100%、100%和88%,十字征评分与FA值负相关,与痉挛性截瘫评定量表和病程正相关。
要点
- 所有25例SPG5患者颈髓T2*加权成像均可见脊髓十字征。
- 背柱、腹索和中间带T2高信号发生率分别为100%、100%和88%。
- 双侧腹角形态正常占14.4%、模糊占49.6%、消失占36%;双侧背角形态正常占13.6%、模糊占56%、消失占30.4%。
核心结论
- 脊髓十字征可能是SPG5的潜在影像标志物,十字征评分与SPG5患者的病程和疾病严重程度相关。
研究设计与样本
- 在25例SPG5患者和21名健康对照中,于T2*加权成像上评估颈髓十字征,并测量背柱、腹索、背角、腹角和中间带的形态与信号特征及特定区域FA值。
关键影像表现/征象
- 所有SPG5患者颈髓均检测到十字征。
- 背柱、腹索和中间带T2高信号发生率分别为100%、100%和88%。
- 双侧腹角形态正常占14.4%、模糊占49.6%、消失占36%;双侧背角形态正常占13.6%、模糊占56%、消失占30.4%。
诊断标准与关键数值
- SPG5患者这些脊髓区域FA值降低。
- 十字征评分与灰质FA值负相关(r=-0.70~-0.37),与白质FA值负相关(r=-0.78~-0.70)。
- 十字征评分与痉挛性截瘫评定量表正相关(r=0.57),与病程正相关(r=0.42)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Spastic paraplegia type 5 (SPG5) is a rare neurodegenerative disease diagnosed primarily through genetic testing.We identified a specific spinal cord sign on conventional MR imaging to help narrow the scope of genetic screening.
METHODS: In 25 patients with SPG5 and 21 healthy controls (HCs), the spinal cord cross sign was evaluated on T2*-weighted imaging. The morphological and signal characteristics of the dorsal column (DC), ventral funiculi (VF), dorsal horn (DH), ventral horn (VH), and intermediate zone (IMZ) were assessed. Differences in fractional anisotropy (FA) values within specific regions between HC and SPG5 were tested using Student's t-test. Spearman correlation was used to evaluate associations between cross-sign scores, FA values, and clinical indicators.
RESULTS: The cross sign was detected in the cervical spinal cord of all SPG5 patients. The occurrence of T2 hyperintensity in the DC, VF and IMZ was 100%,100% and 88%,respectively. Bilateral VH morphology was normal in 14.4% of cases, blurred in 49.6%, and absent in 36%.Bilateral DH morphology was normal in 13.6%, blurred in 56%, and absent in 30.4%. FA values were reduced in these spinal cord regions. Cross-sign scores were negatively correlated with FA values in both grey (r = -0.70~-0.37) and white matter (r = -0.78~-0.70). Cross-sign scores were positively correlated with Spastic Paraplegia Rating Scale (r = 0.57) and disease duration (r = 0.42).
CONCLUSION: The spinal cord cross sign was a potential imaging marker for SPG5. Cross-sign scores were associated with disease duration and severity in SPG5 patients.
TRIAL REGISTRATION: A Registered Cohort Study on Spastic Paraplegia,NCT04006418 Registered 1 July 2019, https://clinicaltrials.gov/study/NCT04006418 .
引用
- Zhang F, Hu J, Xiao Z, et al. Spinal cord cross sign: a potential marker for hereditary spastic paraplegia type 5. Neuroradiology. 2025. PMID: 39853345. doi:10.1007/s00234-025-03543-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。